Colorectal Neoplasms: all 5,738 studies
Page 37 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and RectumCompletedNCT03603366
- Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic LeakageStatus unknownNCT03602677Not applicable
- Flare Type Self-expandable Metal Stent for Malignant Colorectal ObstructionCompletedNCT03602417Not applicable
- MOR-1 Expression in Colorectal Cancer and Disease-free Survival Relationship. Five-year Follow-up.CompletedNCT03601351
- A Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNAStatus unknownNCT03599947
- Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung MetastasesActive, not recruitingNCT03599752Phase 2
- A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal CancerCompletedNCT03597581Phase 1
- Effectiveness of Fecal Immunnochemical Test and Colonoscopy Screening in Hong KongActive, not recruitingNCT03597204Not applicable
- Fasting-mimicking Diet in Patients Undergoing Active Cancer TreatmentCompletedNCT03595540Not applicable
- Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma PatientsTerminatedNCT03594448
- Person-Centred Information and Communication for Patients Undergoing Colo-Rectal Surgery - the PINCORE ProjectCompletedNCT03587818Not applicable
- FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS MutationCompletedNCT03584711Phase 2
- Socioeconomic Position in Acute Colorectal Cancer SurgeryStatus unknownNCT03581890
- EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - TaiwanCompletedNCT03579732
- Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal CancerWithdrawnNCT03576963Phase 1/2
- Views on Cancer Prevention and Daily LifestyleCompletedNCT03575117Not applicable
- Living With Colorectal Cancer: Patient and Caregiver ExperienceCompletedNCT03572101
- A Culturally-adapted Colorectal Cancer Screening Decision Aid Designed for American IndiansCompletedNCT03569761Not applicable
- Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal CancerStatus unknownNCT03567629Phase 2
- Efficacy of Preoperative Intravenous Iron in Anaemic Colorectal Cancer Surgical PatientsCompletedNCT03565354Phase 3
- Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).CompletedNCT03564938Phase 4
- Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in CRCCompletedNCT03564912Phase 1/2
- Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal CancersCompletedNCT03563651
- Mechanical Bowel Preparation With or Without Oral Antibiotics for Colorectal Cancer SurgeryStatus unknownNCT03563586Not applicable
- Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate CancerWithdrawnNCT03563352
- The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver MetastasesStatus unknownNCT03562234
- Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation SequencingStatus unknownNCT03561350
- Survey of Health Preferences in Cancer Patients (QALY-Cancer)CompletedNCT03560817
- Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal AdenocarcinomaCompletedNCT03559543Phase 2
- Inflammation Biomarkers in the Diagnosis of Postoperative Infectious Complications in Colorectal Cancer SurgeryCompletedNCT03559335
- Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal CancerCompletedNCT03556956Phase 2/3
- An Expanded Access Program for AM0010 (Pegilodecakin)No longer availableNCT03554434
- Colorectal Cancer Screening Among Primary Care Physicians of the Swiss Sentinel Surveillance NetworkCompletedNCT03552744Not applicable
- QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.CompletedNCT03552718Phase 1
- Minimally Invasive Simultaneous Colorectal and Liver SurgeryStatus unknownNCT03551470
- Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer RiskCompletedNCT03550885Not applicable
- Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot StudyCompletedNCT03546127
- Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal CancerStatus unknownNCT03545711Phase 1/2
- EGFR-IL12-CART Cells for Patients With Metastatic Colorectal CancerStatus unknownNCT03542799Phase 1
- Calcium Electroporation for the Treatment of Colorectal CancerCompletedNCT03542214Phase 1
- Peripheral Neuropathy in Colorectal Cancer Patients Under Adjuvant Chemotherapy With FOLFOX, FLOX or XELOX RegimeCompletedNCT03542136Not applicable
- Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal CancerCompletedNCT03532711
- Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal CancerWithdrawnNCT03532204Not applicable
- Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal CancerCompletedNCT03530267Phase 2
- An Internet Delivered Intervention for Re-Adjustment to Sexual Intimacy With an Ostomy After CancerStatus unknownNCT03526952Not applicable
- Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer IICompletedNCT03524716Not applicable
- Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal CancerWithdrawnNCT03524274Phase 2
- A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal CancerStatus unknownNCT03522649Phase 3
- Quality of Life in Colorectal Cancer SurvivorsCompletedNCT03521765Not applicable
- RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer PatientsCompletedNCT03520946Phase 3
- TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRCCompletedNCT03517618Phase 2
- A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsCompletedNCT03517488Phase 1
- Anatomical Classifications of Inferior Mesenteric ArteryStatus unknownNCT03515850
- A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRCCompletedNCT03511963Phase 3
- XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal CancerStatus unknownNCT03511183Phase 2
- XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal CancerStatus unknownNCT03511170Phase 2
- Randomized Controlled Trial on Colorectal Cancer Screening Among Quality Circles of Primary Care PhysiciansCompletedNCT03510858Not applicable
- Combined Immunotherapy and Radiosurgery for Metastatic Colorectal CancerCompletedNCT03507699Phase 1
- Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLMTerminatedNCT03500874Phase 3
- Microbiota-anastomotic Leak Among Colorectal Surgery Patients : Pilot StudyCompletedNCT03496441
- Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLMActive, not recruitingNCT03493048Phase 2
- A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCCCompletedNCT03491709Phase 1
- e-Nose and Colorectal CancerCompletedNCT03488537Not applicable
- Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal CancerStatus unknownNCT03487939Phase 2
- Health Message Framing to Improve Uptake of Bowel Cancer ScreeningStatus unknownNCT03487523Not applicable
- European Serrated Adenoma Classification ScoreStatus unknownNCT03486418
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsActive, not recruitingNCT03485209Phase 2
- Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal CancerCompletedNCT03485027Phase 2
- Screening TO Prevent ColoRectal Cancer (STOP CRC) Among At-Risk Chinese and Korean American Primary Care PatientsCompletedNCT03481296Not applicable
- Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal CancerCompletedNCT03477019Phase 1/2
- Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal CancerStatus unknownNCT03476122
- Promoting Colorectal Cancer Screening in Rural Emergency DepartmentsStatus unknownNCT03473587Not applicable
- Immunological and Oxidative Stress Response in Relation to Abdominal Cancer SurgeryCompletedNCT03473327
- Predictive Factors for Failure or Success of Endoscopic Treatment of Superficial Colorectal TumorsCompletedNCT03470883
- Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal CancerWithdrawnNCT03470350Phase 1/2
- Signaling Pathways Targeting Colorectal Cancer in EgyptCompletedNCT03467308
- Association of Capecitabine Pharmacokinetics and Toxicity With AgingStatus unknownNCT03465202Phase 4
- Peripheral Blood Monocytes as Predictive Marker for Colorectal Cancer Diagnosis: A Comparative Study of a Stool Based Versus Blood Based Screening TestStatus unknownNCT03462992
- Targeted Delivery of Chemotherapy With Ultrasound and MicrobubllesCompletedNCT03458975Phase 2
- Pilot Study in a Company in Maine-et-Loire to Evaluate the Feasibility, Acceptability, and Impact on the Participation Rate of Awareness of Colorectal Cancer Screening by Occupational Health TeamsStatus unknownNCT03458949Not applicable
- Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 StatusStatus unknownNCT03457896Phase 2
- A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination ChemotherapyCompletedNCT03454620Phase 1/2
- Stenting and Resection for Stage IV Colorectal Cancer Endoscopic Stenting and Colorectal Resection in Stage IVStatus unknownNCT03451643Not applicable
- Personalized Surveillance Protocol for Serrated Polyposis SyndromeCompletedNCT03450889
- Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA)CompletedNCT03448731Phase 2
- SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer PatientsStatus unknownNCT03448549Phase 3
- Computed Tomography Perfusion Colorectal Cancer With Tumor GradeStatus unknownNCT03448302
- Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical ImpactStatus unknownNCT03447431
- Local Wound Infiltration With 0.5% Levobupivacaine for Postoperative Pain After Laparoscopic Colorectal Surgery.CompletedNCT03433014Not applicable
- T Cell Receptor Based Therapy of Metastatic Colorectal CancerTerminatedNCT03431311Phase 1/2
- Three-port Versus Conventional Laparoscopic Surgery for Colorectal CancerStatus unknownNCT03426514Not applicable
- Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody TrialTerminatedNCT03426371Phase 3
- Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin TreatmentStatus unknownNCT03422601
- Prophylactic HIPEC for Colorectal Cancers At High Risk of Developing Peritoneal MetastasesCompletedNCT03422432Not applicable
- Human Blood Specimen Collection to Evaluate Immune Cell FunctionCompletedNCT03422120
- Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)CompletedNCT03421912Not applicable
- Comparison of AMR and ADR Between Endocuff Vision-assisted and Conventional Colonoscopy: a Multicenter Randomized TrialStatus unknownNCT03418948Not applicable
- Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.Status unknownNCT03418558Phase 2
- The Implication of ctDNA in the Recurrence Surveillance of Stage II and III Colorectal CancerStatus unknownNCT03416478
- Water-assisted Colonoscopy vs Second Forward View Examination of the Right Colon on Adenoma DetectionStatus unknownNCT03416322Not applicable